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• Mateusz Spalek (Warsaw, Poland): ACROP Committee 
• Daniela Thorwarth (Tübingen, Germany): Physics 
Committee 
• Wouter van Elmpt (Maastricht, The Netherlands): Physics 
Committee 
Future vision: carry on the activities initiated by theprevious 
task Forces and work on new perspectives 
Standing committee involvement 
Young Committee members’ positions as observers allow us 
torepresent the interests of the young ESTRO members and to 
evaluate thecontribution and participation of the young 
members in other standingcommittees’ activities. 
Young scientist session at ESTRO Forum and Young 
scientisttrack at numbered ESTRO congresses 
The Young Committee is responsible for the 
organisation,contribution and promotion of the young 
scientist session / track at all ESTROcongresses. Each year, a 
young track is held with symposia and teachinglectures aimed 
at the young radiation oncology professionals, with 
subjectssuch as “how to build a career”, “how to write a 
good article/abstract”. Wealso organize a young reception at 
the end of the track, which is always a nicemoment to meet 
other young Europeans and network with each other.  
Online services (Facebook, videos, FALCON, DOVE, 
scientificnetworking) 
The 3rd YTF started several projects regarding 
onlineservices. The main task will be to maintain, promote 
and communicate theseactivities. The Young Committee will 
also contribute to ESTRO online serviceslike FALCON, DOVE, 
etc. 
ESTRO Fellow 
In regard of the heterogeneous training in the field 
ofradiation oncology within Europe, the “ESTRO Fellow” was 
created to achieve ahigh level of education as well as reflect 
a high dedication towards ESTRO. Ithas become a prestigious 
mark of distinction.  
The next ESTRO fellow exam will take place on April, 
29th2016 at ESTRO35 in Turin. The Application deadline is set 
for March, 29th 2016. 
The future 
The Young Committee is currently involved in the setup ofthe 
3rd Agora Meeting which should take place late 2015 or early 
2016. Thismeeting will bring together motivated young ESTRO 
members to discuss andexchange our vision for our field. A 
call for applications will be sent in thatperspective. 
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The Young Radiation Oncology Group of EORTC -ROG 
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The Young Radiation Oncologists Group (YROG) is a working 
party of the European Organization for Research and 
Treatment of Cancer (EORTC) -Radiation Oncology Group 
(ROG). Its members are the "young members" of the ROG.  
The YROG was initiated in 2012 with an aim to incorporate 
radiation oncologists in early phases of their career within 
the EORTC- ROG activities. This was done to have a new 
generation of radiation oncologists actively involved in 
research. 
Joining the YROG is an opportunity to present your research 
and new study proposals and to take part in the discussions 
held at the different ROG working parties. By being a part of 
the EORTC-ROG you will learn about designing clinical trials 
and have a chance to work side by side with world-leaders in 
oncology.  
If you are at the early stages of your career in radiation 
oncology and are looking for an opportunity to be involved in 
key research, come to hear about the YROG.  
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Since 2003, the SFjRO (French Society of young Radiation 
Oncologist) promote radiation oncology teaching in France. 
The goals of our society are to promote and ease the 
teaching of radiation oncology by developing relationships 
between residents and professors. By creating specific tools, 
giving access to scientific journals and organizing each year 
two theoretical courses, the SFjRO aims to give access to a 
better understanding of current practices in Radiation 
Oncology. Nowadays our society has more than 200 members. 
Each year French residents attend one national radiation 
therapy courses covering each fundamental field of radiation 
oncology : radioanatomy, radiobiology, radiophysics and 
brachytherapy and a summer school dedicated to a specific 
organ. All these courses are available freely on our website 
which has now a database of more than 300 radiation 
oncology courses. The SFjRO works with SFRO (French Society 
of Radiation Oncologists) and organize a young session during 
the National meeting of Radiation oncology. We also 
represent resident in front of national organisation such as 
National cancer Institute (Inca) and National Board of 
Oncology Teachers (CNEC). Another goal of SFjRO is to 
promote research among residents and we have published 
several studies about delineation variability, burnout or 
mobile technology and social media use by young radiation 
oncologists. In the future we hope to strengthen our 
cooperation with European young radiation oncologist 
societies, and to take part in young sessions such as the YROG 
sessions.  
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The Young AIRO (Italian Association of Radiation Oncology) 
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The Young AIRO group (yAIRO) is a part of the Italian 
Association of radiation oncology composed by members 
below 40 years old. The increasing participation of the young 
member to the AIRO scientific activities resulted in the 
foundation of the Young group in 2007. The main purpose of 
the yAIRO was to create a network connections between 
junior physicians working in different institutions throughout 
the country, to promote the collaboration with junior groups 
of other national scientific societies in the field of oncology. 
Nowadays the Young group has approximately 350 members. 
Every years there is an annual scientific national event 
dedicated to young members, a scientific session dedicated 
to the young members takes place during the AIRO national 
meeting. One of the main project of the yAIRO is to create 
collaboration programs with other young specialists involved 
in the oncology field. In the last years, relationships were 
created with the young group of the Italian medical oncology 
association (AIOM), young urologists (SIURO) and young 
medical radiologists (SIRM). The yAIRO published some 
collaborative research projects: the INTER-ROMA Project 
(2011), the BUONGIORNO Project (2013), the PROCAINA part I 
and II Project (2013), the STYRO Project (2013), the PEDRO 
project (2015). A project about the history and development 
of Italian radiation oncology residency programs and one 
about the pacemaker and implanted cardioverter 
defibrillator management in radiation therapy are in 
progress. The fundamental role of young members in the 
Italian radiation oncology society will induce yAIRO to 
improve young specialists’ participation, involvement and 
commitment into education, research and clinical care. 
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Poster Viewing: 7: Physics: Intra-fraction motion 
management II  
 
 
PV-0322  
Target displacement evaluation for fluoroscopic and four-
dimensional cone-beam computed tomography 
H. Iramina
1Kyoto University, Nuclear Engineering, Kyoto, Japan 
1, M. Nakamura2, Y. Iizuka2, Y. Matsuo2, T. 
Mizowaki2, M. Hiraoka2, I. Kanno1 
2Kyoto University, Radiation Oncology and Image-Applied 
Therapy, Kyoto, Japan 
 
Purpose or Objective: Four-dimensional cone-beam 
computed tomography (4D-CBCT) has great capability to 
provide volumetric and respiratory motion information with 
one gantry rotation. It is necessary to quantitatively assess, 
how difference of tumor displacement between actual and 
4D-CBCT image exists. In this study, we evaluated the 
displacement of implanted fiducial markers assumed as 
tumor on fluoroscopic projection images and reconstructed 
4D-CBCT images with different sorting methods.  
 
Material and Methods: We have developed 4D-CBCT utilizing 
dual source kV X-ray imaging subsystems. Five lung cancer 
patients with two to four implanted fiducial markers were 
enrolled in the institutional review board-approved trial. 
Each patient underwent three consecutive 4D-CBCT imaging. 
For at least two scans out of three, the imaging parameters 
were 110 kV, 160 mA and 5 ms, the rotational speed of the 
gantry was 1.5°/s, rotation time was 70 s, the image 
acquisition interval was 0.3°, and the rotational angle of 
105°. A marker that located the most nearest to the lung 
tumor was used for surrogate respiratory signal. The marker 
motion in superior-inferior (SI) direction was used as 
surrogate respiratory signal for 4D-CBCT image 
reconstruction. Surrogate respiratory signal were converted 
eight phase bins with retrospective amplitude- or phase- 
based sorting. On reconstructed 4D-CBCT images, the marker 
was contoured on all phases to detect its 3D positions. 
Meanwhile, the marker positions on two fluoroscopic images 
obtained simultaneously were converted to 3D position. 
Evaluation was employed among the displacement on 
fluoroscopic image (dfluoro), that on amplitude-based sorting 
4D-CBCT (da-4DCBCT) and that on phase-based sorting 4D-
CBCT (dp-4DCBCT) in left-right (LR), anterior-posterior (AP), 
and SI direction. Difference between da-4DCBCT and dfluoro 
(Da-f), and difference between dp-4DCBCT and dfluoro (Dp-f) 
were obtained for all patients.  
 
Results: Depending on the sorting methods, the positional 
difference was up to 2 mm on 4D-CBCT images. Overall mean 
± standard deviation of Da-f and Dp-f in LR, AP, and SI 
direction were -1.5±1.2, -2.9±1.2, -5.1±1.6 mm and -1.4±1.1, 
-2.3±0.9, -5.2±1.2 mm, respectively (Table 1). 4D-CBCT 
underestimated displacement of marker by 5 mm on average 
in SI direction.  
 
 
Conclusion: We performed displacement evaluation of 
fiducial markers on 4D-CBCT with two sorting methods. Since 
4D-CBCT requires convolution of marker motion in eight bins, 
underestimation of 5 mm on average was observed in SI 
direction.  
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Purpose or Objective: Image registration of Digitally 
Reconstructed Radiographs (DRRs) and real-time kV images is 
the only clinically implemented solution to markerless tumor 
tracking. However, registration still suffers from poor soft 
tissue visibility, restricting the workflow to only a certain size 
and density of tumors. The purpose of this study is to 
evaluate the feasibility of markerless tumor tracking on a 
clinical system through 4D/3D registration and the use of 
dual-energy (DE) imaging. 
 
Material and Methods: For 3 patients treated for NSCLC with 
dynamic tracking on the Vero SBRT system, on average 90 
soft-tissue enhanced DE images were created from sequential 
low- (LE) and high-energy (HE) orthogonal fluoroscopy. All DE 
images were binned in either inhale, exhale, maximum inhale 
or maximum exhale, using the amplitude of the synchronous 
external breathing signal.  
For each respective breathing phase, DRR templates were 
created from the 4D planning CT using the open-source 
Insight Toolkit (itk).  
As such, the localization problem was reduced to 2D/2D 
registration of 2 orthogonal kV images and 2 DRRs.  
Before registration, the currently implanted marker was 
removed on all images so to not bias the results.  
Intensity-based 2D/2D registration was carried out between 
each DE image and the respective DRR. The same was done 
with all HE images to evaluate the benefit of using DE 
imaging..  
The implanted marker was recovered and used as a 
benchmark to quantify the accuracy of the tumor 
localization. The mean Euclidean distance between the 
center of the marker in the DE and HE images, and the center 
of the marker in the matched DRR template was defined as 
the tracking error (TE). 
 
